期刊文献+

ANCA相关性血管炎诊治的临床决策 被引量:1

The Clinical Decision-making of Diagnosis and Treatment of the Anti-neutrophil Cytoplasmic Antibodies (ANCA) Associated Vasculitis
下载PDF
导出
摘要 抗中性粒细胞胞浆抗体(ANCA)相关性血管炎是系统性自身免疫性疾病,肾脏是最易受累的器官。因其临床表现多样且易于复发,临床上常见误漏诊和治疗不当。肾科医师在临床决策中应重视早期识别与诊断,并进行规范、适度的个体化治疗,同时避免过度治疗导致的严重并发症,以期改善患者的远期生存率与生活质量。 The anti--neutrophil cytoplasmic antibodies (ANCA} associated vasculitis is a systemic autoimmune disease, and kidney is the most vulnerable organ. Because of its diverse clinical manifestations and easy to relapse, rnisdiagnosis and improper treatment are common clinical phenomenon. Renal physicians should pay attention to early identification and diagnosis, and to provide regulate, appropriate individualized treatment, while avoiding serious complications due to over--treatment in clinical decision--making, with a view to improving the survival rate and quality of life.
出处 《医学与哲学(B)》 2010年第2期32-33,共2页 Medicine & Philosophy(B)
关键词 抗中性粒细胞胞浆抗体 系统性血管炎 临床决策 anti--neutrophil cytoplasmic antibodies,systemic vasculitis,clinical decision--making
  • 相关文献

参考文献11

  • 1De Groot K, Adu D, Savage C O, et al. The value of pulse cyclophos-- phamide in ANCA-- associated vasculitis: Meta-- analysis and critical review [J]. Nephrol Dial Transplant, 2001, 16 (10) : 2018--2027. 被引量:1
  • 2Jayne D R, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high--dosage methylprednisolone as adjunctive therapy for severe renal vasculitis[J]. J Am Soc Nephrol,2007, 18 (7):2180--2188. 被引量:1
  • 3De Groot K, Rasmussen N, Bacon P A,et al. Randomized trial of Cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody -- associated vasculitis[J]. Arthritis Rheum, 2005, 52 (8) :2461 -- 2469. 被引量:1
  • 4Hoffman G S, Leavitt R Y, Kerr G S, et al. The treatment of Wegener's granulomatosis with glueoeorticoids and methotrexate[J]. Arthritis Rheum, 1992, 35(11) : 1322-- 1329. 被引量:1
  • 5Hu W X, Liu C B, Xie H L,et al . Mycophenolate mofetil versus cyelophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement [J]. Nephrol Dial Transplant, 2000, 23(4) : 1307-- 1312. 被引量:1
  • 6Jayne D, Rasmussen N, Rassy K, et al. A randomized trial of maintenance therapy for vascu[itis associated with antineutrophil cyto- plasmic autoantibodies[J].N Engl J Med, 2003,349 (1) : 36 -- 44. 被引量:1
  • 7Slot M C, Tervaert J W, Boomsma M M, et al. Positive classic antineutrophil cytoplasmic antibody (C--ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3--related vasculitis[J].Arthritis Rheum,2004, 51(2):269--273. 被引量:1
  • 8Jayne D. Progress of treatment in ANCA--associated vasculitis [J]. Nephrology,2009,14(1) -42--48. 被引量:1
  • 9Maria Koukoulaki, David R W,Jayne. Mycophenolate mofetil in anti--neutrophil cytoplasm antibodies--associated systemic vasculitis[J]. Nephron Clin Pract, 2006,102(3-- 4) : 100-- 107. 被引量:1
  • 10Booth A, Harper L, Hammad T, et al. Prospective study of TNF --alpha blockade with infliximab in anti--neutrophil cytoplasmic antibody--associated systemic vasculitis[J]. J Am Soc Nephrol, 2004, 15(5) :717--721. 被引量:1

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部